Description

Ethyl 6-Bromo-4-(4-Methyl-3-Nitrophenylamino)Quinoline-3-Carboxylate is a high-purity, advanced pharmaceutical intermediate with the CAS number 1415562-32-1. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel quinoline-based therapeutic agents. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of potential drug candidates, especially those targeting kinase inhibition or other quinoline-based mechanisms.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies to develop new therapeutic molecules.
• Organic Synthesis Reference Standard: Serves as a pure reference material for analytical method development and validation in QC laboratories.
• Preclinical Development: Employed in the scale-up synthesis of compounds for pharmacological and toxicological evaluation.
• Academic Research: Utilized in university and institutional labs for exploring new heterocyclic chemistry and reaction pathways.
• Custom Synthesis: A starting material for the contract manufacturing of specialized, high-value fine chemicals and complex organic molecules.

Basic Information

Product Name	Ethyl 6-B